These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Being prepared: bioterrorism and mass prophylaxis: part II. Weant KA; Bailey AM; Fleishaker EL; Justice SB Adv Emerg Nurs J; 2014; 36(4):307-17; quiz 318-9. PubMed ID: 25356890 [TBL] [Abstract][Full Text] [Related]
3. Being prepared: bioterrorism and mass prophylaxis: part I. Weant KA; Bailey AM; Fleishaker EL; Justice SB Adv Emerg Nurs J; 2014; 36(3):226-38; quiz 239-40. PubMed ID: 25076398 [TBL] [Abstract][Full Text] [Related]
4. Biological agents: weapons of warfare and bioterrorism. Broussard LA Mol Diagn; 2001 Dec; 6(4):323-33. PubMed ID: 11774197 [TBL] [Abstract][Full Text] [Related]
5. [Germs and toxins in bioterrorism]. Inoue N Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194 [No Abstract] [Full Text] [Related]
6. Molecular diagnostic techniques for use in response to bioterrorism. Firmani MA; Broussard LA Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181 [TBL] [Abstract][Full Text] [Related]
7. Medical aspects of bio-terrorism. Balali-Mood M; Moshiri M; Etemad L Toxicon; 2013 Jul; 69():131-42. PubMed ID: 23339855 [TBL] [Abstract][Full Text] [Related]
8. The microbiology laboratory's role in response to bioterrorism. Robinson-Dunn B Arch Pathol Lab Med; 2002 Mar; 126(3):291-4. PubMed ID: 11860302 [TBL] [Abstract][Full Text] [Related]
9. Bioterrorism: class A agents and their potential presentations in immunocompromised patients. Richard JL; Grimes DE Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465 [TBL] [Abstract][Full Text] [Related]
10. Bioterrorism. Clinical recognition and primary management. Branda JA; Ruoff K Am J Clin Pathol; 2002 Jun; 117 Suppl():S116-23. PubMed ID: 14569808 [TBL] [Abstract][Full Text] [Related]